CD14 is a 54 000-molecular weight (MW) glycolipid-anchored membrane glycoprotein, expressed on myeloid cells, which functions as a member of the lipopolysaccharide (LPS) receptor complex. Soluble forms of CD14 have been reported in plasma, cerebrospinal¯uid, amniotic¯uid and breast milk. In plasma and breast milk, soluble CD14 has been implicated as a regulator of T-and B-cell activation and function. Expression of CD14 in the male reproductive system has not previously been investigated. We here show that soluble CD14 is present in seminal plasma at levels comparable to those in serum. Spermatozoa expressed CD14 on their membranes, as demonstrated by¯uorescence microscopy and¯ow cytometry. Post-vasectomy, the levels of seminal plasma CD14 (spCD14) were much reduced, implying an origin distal to the point of transection of the vas deferens. Ultracentrifugation analyses demonstrated that spCD14 was not associated with lipid complexes, indicating that it lacks the glycolipid anchor. Puri®ed spCD14 mediated activation by LPS of CD14-negative cells. These ®ndings suggest that CD14 may play a hitherto unexplored role in immune defence and cell activation in the male reproductive tract.
INTRODUCTION
CD14 was initially described as a glycosyl phosphatidylinositol (GPI)-anchored membrane glycoprotein expressed predominantly on cells of the myelomonocytic lineage (monocytes and macrophages) and, at lower levels, on neutrophils and B lymphocytes. 1, 2 On these cells, CD14 forms part of the lipopolysaccharide (LPS) receptor complex by acting as a co-receptor. Ef®cient cell activation induced by bacterial LPS requires the interaction of LPS with CD14, an interaction that is facilitated by the activity of a serum protein, LPS-binding protein (LBP), which catalyses the transfer of LPS monomers to CD14. Subsequently, the CD14±LPS complex triggers cell activation, predominantly via the cell-surface signalling molecule Toll-like receptor 4 (TLR4) and its associated molecule, MD-2. 3, 4 It has become clear that CD14 is critical for an ef®cient recognition not only of LPS but also of a number of other bacterial cell wall components from diverse organisms, heat shock proteins and some viruses. 5 The presence in plasma of a soluble form of CD14 (sCD14) was ®rst noted in 1986. 6 Later work showed that normal plasma concentrations of sCD14 are in the range of 2±6 mg/ml, 7 although higher levels have been reported in infectious and in¯ammatory diseases. 8, 9 Two distinct forms of sCD14, termed sCD14a (48 000 MW) and sCD14b (56 000 MW) are present in plasma. 10, 11 Monocytes are the source of both forms of plasma sCD14; it has been suggested that sCD14a is generated by cleavage of the GPI-anchored membrane CD14, whereas sCD14b is a secreted molecule derived from a common precursor of the GPI-anchored form. Plasma sCD14 retains the ability to bind LPS and mediate activation of CD14-negative and CD14-positive cells. 10, 12 These activation events, like those triggered through membrane CD14, are signalled predominantly via TLR4. 13 Soluble forms of CD14 have also been reported in cerebrospinal¯uid (CSF), amniotic¯uid, synovial¯uid and breast milk. 14±17 In normal CSF, sCD14 is present at a concentration of 0 . 19 mg/ml and is elevated in meningitis, apparently as a consequence of local biosynthesis. 14 In breast milk, sCD14 levels are 20±100 mg/ml, 10-fold higher than the levels in plasma. 16 In each of these¯uids, sCD14 has been implicated as a sensor for bacterial LPS and is capable of rapidly mediating local cell activation in response to bacterial invasion.
Seminal plasma is known to contain immunoregulatory activities that restrict infection of the genital tract.
18±21 The molecular bases of these activities remain poorly understood. We undertook to examine whether seminal plasma contained Correspondence: Professor B. Paul Morgan, Department of Medical Biochemistry, UWCM, Cardiff CF14 4XN, UK. E-mail: morganbp@cardiff.ac.uk a soluble form of CD14 that might contribute to its immunoregulatory properties. We here show that seminal plasma from normal donors contains soluble CD14 (spCD14) at levels comparable to those in blood plasma. spCD14 mediated cell activation in assays that have previously been used to characterize soluble CD14 from other sources. Post-vasectomy, spCD14 levels are much reduced, suggesting that spCD14 is derived in part from testis and/or seminal vesicles. Finally we show that spermatozoa express a membrane-bound form of CD14, the roles of which remain unexplored.
MATERIALS AND METHODS

General reagents and antibodies
All reagents were sourced from Fisher Scienti®c (Loughborough, UK) unless stated otherwise. The anti-human CD14 monoclonal antibody (mAb) MEM-18 (IgG1) has been described previously. 6 The rabbit anti-CD14 polyclonal antiserum was generated in-house by immunization with puri®ed CD14 and was adsorbed with human IgG before use. The isotype-control antibody, 6D1, was generated in-house. BRIC229 anti-CD59 was from IBGRL (Bristol, Avon, UK). Horseradish peroxidase (HRP)-conjugated secondary antibody against rabbit immunoglobulin (minimal cross-reactivity) was from Jackson Immunoresearch (West Grove, PA). Phycoerythrin (PE)-conjugated secondary antibodies against mouse and rabbit immunoglobulin were from DAKO (High Wycombe, UK) and Sigma Aldrich (Poole, Dorset, UK), respectively. Fluorescein isothiocyanate (FITC)-conjugated secondary antibodies against mouse and rabbit immunoglobulin were from DAKO. The human astrocytoma cell line, U373MG, was obtained from the American Type Culture Collection (ATCC) (Rockville, MD).
Seminal plasma and spermatozoa
Seminal plasma samples were obtained fresh from the Infertility Clinic of the University Hospital of Wales, either from normospermic individuals (normals) or postvasectomy. For the majority of samples, cells were immediately removed by centrifugation (1000 g, 5 min) and the cell-free seminal plasma was stored at x70u until use. Prostasome-free seminal plasma was obtained as previously described, 21, 22 by subjecting fresh cell-free seminal plasma to ultracentrifugation (100 000 g, 1 hr) in a Beckman benchtop ultracentrifuge. Motile spermatozoa were obtained free of contaminating cells using a modi®cation of the`swim-up' technique. Fresh seminal plasma samples were allowed to liquefy at room temperature for 30 min in a plastic tube, then carefully overlayed with an equal volume of sterile normal saline at room temperature. The tube was placed at 37u for 1 hr, the saline carefully removed using a glass pipette and cells harvested from the saline by gentle centrifugation (500 g, 15 min). Spermatozoa obtained by swim-up were essentially free of other cells.
Sodium dodecyl sulphate±polyacrylamide gel electrophoresis (SDS±PAGE) and Western blotting of seminal plasma Samples for analysis (1 ml) were diluted 1 : 3 in phosphatebuffered saline (PBS) and incubated for 2 hr at room temperature with MEM-18 anti-CD14 immobilized on cyanogen bromide (CNBr)±sepharose (Amersham Pharmacia, Little Chalfont, UK) at 1 . 4 mg of IgG/ml of the gel (0 . 2 ml of packed gel). The immunosorbent was washed ®ve times in PBS, twice in PBS containing 0 . 5 M NaCl and then eluted with 0 . 1 ml of non-reducing Laemlli sample buffer. The sample was split and half was diluted in sample buffer containing b-mercaptoethanol to reduce. Samples were boiled for 90 seconds and loaded on 10% or 12 . 5% SDS±polyacrylamide gels. Gels were either silver stained to identify proteins or electroblotted onto nitrocellulose. Blots were blocked in PBS containing 1% nonfat milk and then incubated sequentially with primary antibody (polyclonal anti-CD14, 1 : 4000 in PBS/milk; overnight at 4u) and secondary antibody (HRP-anti-rabbit IgG, 1 : 2000 in PBS/ milk; 1 hr at room temperature). Blots were developed using the enhanced chemiluminescence (ECL) system (Pierce, Chester, UK).
Enzyme-linked immunosorbent assay (ELISA) for spCD14 in seminal plasma samples The concentration of spCD14 in seminal plasma samples was measured using a commercial ELISA (IBL, Hamburg, Germany), according to the manufacturer's instructions. The working range of the assay was 5±100 ng/ml. Samples from 35 normal donors and 20 postvasectomy donors were measured. All samples were run in duplicate, at a dilution of 1 : 50 in assay diluent buffer. Results were calculated from the standard curve.
Puri®cation of spCD14
Pooled, cell-free seminal plasma (10 ml) was diluted in an equal volume of PBS containing 0 . 1% 3-[(cholamidopropyl)dimethylammonio]-1-propane-sulfonate (CHAPS), centrifuged to remove debris and applied ®rst to a precolumn containing 10 ml of sepharose 4B (Amersham Pharmacia) in PBS/0 . 05% CHAPS and then to an immunoaf®nity column comprising 5 ml of MEM-18 anti-CD14 mAb immobilized on CNBr± sepharose at 1 . 4 mg of IgG/ml of the gel (described above). The immunoaf®nity matrix used for these studies was new and had not been exposed to any other possible source of CD14. The immunoaf®nity column was washed with 10 column volumes of PBS/CHAPS, then with 10 column volumes of PBS containing 0 . 5 M NaCl and ®nally eluted in PBS containing 50 mM diethylamine, pH 11 . 5. The eluted protein was pooled, neutralized by addition of a 1/10 volume of 1 M Tris-HCl, pH 7 . 0, and dialysed extensively into PBS. Protein was concentrated in an Amicon ultra®ltration cell (Amicon Ltd, Stonehouse, UK) prior to storage in aliquots at x20u. Protein concentration was measured using the Coomassie protein assay (Pierce).
Cell activation assays using puri®ed spCD14
To test the biological activity of spCD14, 90% con¯uent cultures (in 96-well plates) of the human astrocytoma cell line, U373MG, were washed and cultured for an additional 20 hr in Dulbecco's modi®ed Eagle's minimal essential medium (DMEM) (Gibco BRL, Paisley, Strathclyde, UK) supplemented with 20 mM glutamine and different amounts of puri®ed spCD14, with or without LPS at 100 ng/ml (from Escherichia coli, strain 055 : B5; Sigma). For some control experiments, the spCD14 preparation was preincubated (30 min, room temperature) with blocking mAb against CD14 (MY4; Beckman Coulter, High Wycombe, UK) or its isotype-matched control (MOPC141; Beckman Coulter) before adding to the cultures. The 20-hr culture supernatants were collected and assayed for interleukin (IL)-6 and IL-8 by ELISA (R & D Systems, Abingdon, UK). The cells were harvested and stained with anti-CD54 (intracellular adhesion molecule-1 [ICAM-1]) mAb or its isotype-matched control (Diaclone/IDS, Tyne and Wear, UK), followed by a PE-conjugated rabbit anti-mouse immunoglobulin (Sigma), and then analysed on a¯uorescence-activated cell sorter (FACScalibur; Becton-Dickinson, San Jose, CA).
Flow cytometry analysis
Spermatozoa obtained by swim-up were washed three times in PBS by centrifugation and resuspended in FACS buffer (1% bovine serum albumin [BSA] and 0 . 2% NaN 3 in PBS) at a concentration of 10 6 /ml. All staining steps were conducted on ice. Cells (50 ml) were incubated with the same volume of primary antibody (MEM-18; 10 mg/ml) or control antibodies (6D1 or BRIC229; 10 mg/ml) for 40 min on ice, washed twice with FACS buffer and incubated for 40 min on ice with a PE-conjugated secondary antibody diluted 1 : 150 in FACS buffer. Cells were washed twice in FACS buffer and ®xed with 1% paraformaldehyde in FACS buffer. Fluorescence was measured using a FACScalibur¯ow cytometer (Becton-Dickinson).
Fluorescence microscopy
Spermatozoa obtained by swim-up were stained with primary antibodies (MEM-18 anti-CD14 mAb, polyclonal anti-CD14, BRIC229 anti-CD59 mAb) essentially as described for¯ow cytometry, except that FITC-conjugated secondary antibodies were used. Controls included cells incubated with the isotypecontrol mAb, an irrelevant polyclonal antiserum, or no ®rst antibody. The stained cells were ®xed with paraformaldehyde, washed once with deionized water and dried onto glass slides. Coverslips were applied using Vectashield mounting medium (Vector Laboratories, Burlingame, CA) and the stained cells were viewed using a Nikon inverted¯uorescence microscope. Images were captured and processed using the Openlab image analysis system (Improvision, Coventry, UK).
RESULTS
Western blotting demonstrates the presence of sCD14 in seminal plasma
Immunoprecipitates from cell-free seminal plasma samples were separated by SDS±PAGE (on 10% gels) under reducing or non-reducing conditions, blotted onto nitrocellulose and probed with polyclonal anti-CD14. Two major bands of apparent M r 45 kDa and 50 kDa under non-reducing conditions, and 48 kDa and 53 kDa under reducing conditions, were present in all seminal plasma samples tested (Fig. 1a, 1b) . Serum, run as a positive control, gave an essentially identical banding pattern, although the bands were consistently 1±2 kDa larger (Fig. 1a, 1b) . Silver staining of spCD14 immunoprecipitated from seminal plasma showed the same two bands with only trace contaminants present (Fig. 1c) . Prostasome-free seminal plasma was also run for comparison and appeared to be identical to unfractionated, cell-free seminal plasma (not shown).
ELISA con®rms that spCD14 is present in seminal plasma and decreased postvasectomy
In 35 samples of cell-free seminal plasma from normospermic individuals, the mean concentration of spCD14 was 1 . 89 mg/ml (standard deviation [SD] 0 . 97; range 0 . 25±4 . 36 mg/ml) (Fig. 2) . In 20 samples of cell-free seminal plasma from vasectomised males, the mean concentration of spCD14 was 0 . 68 mg/ml (SD 0 . 38; range 0 . 24±1 . 4 mg/ml). The difference between these two groups was highly signi®cant (P<0 . 0001; Student's unpaired t-test, two-tailed with Welch correction applied).
Puri®cation and functional characterization of spCD14
spCD14 was puri®ed to near-homogeneity following a single passage over the anti-CD14 mAb immunoaf®nity column (Fig. 1d) . The yield from 10 ml of pooled seminal plasma, estimated using the Coomassie protein assay, was 120 mg, an unanticipated result given that the mean seminal plasma concentration of spCD14 measured in the ELISA was <2 mg/ml.
spCD14 mediates cell activation induced by endotoxin
To test whether spCD14, like soluble CD14 from other sources, functioned as a mediator of LPS activation of cells that lack membrane CD14, we examined the effects of spCD14, with or without LPS, on the CD14-negative cell line, U373. spCD14 mediated LPS-dependent IL-6 and IL-8 production by U373 in a dose-dependent manner (Fig. 3a, 3b) , and also induced expression of ICAM-1 (CD54) in these cells (Fig. 3c ). An anti-CD14-speci®c mAb (MY-4) abrogated all observed changes, con®rming the CD14 dependence of these events.
Flow cytometric analysis demonstrates that spermatozoa express CD14
Spermatozoa stained with MEM-18 anti-CD14 gave a homogeneous population of positive cells (Fig. 4) . Cells stained with secondary antibody alone, or with an irrelevant, isotypematched mAb (6D1, anti-rat CD59), were all negative. Cells stained with BRIC229 anti-human CD59 (positive control) were all strongly positive.
Fluorescence microscopy reveals homogeneous distribution of CD14 on spermatozoa
Spermatozoa stained for CD14 using either the mAb MEM-18 ( Fig. 5c) or the polyclonal anti-CD14 antiserum (Fig. 5d ) exhibited a global membrane staining for CD14, which was stronger on the tail and neck than on the head of the cell. Cells stained with mAb anti-CD59 as a positive control gave a granular staining on all parts (Fig. 5b) , as previously described. 21 Controls in which the primary antibody was omitted (Fig. 5a, inset) , or was substituted for an irrelevant mAb or polyclonal antiserum, were negative.
DISCUSSION
Understanding of the innate mechanisms operating to protect the host from bacterial invasion has increased greatly in recent years. 5, 23 Biological¯uids contain an arsenal of agents that can directly or indirectly target and destroy pathogens. The contribution made by CD14 to innate immunity is now well recognized. CD14 belongs to a family of receptors, termed pattern recognition receptors, which are involved in innate immune recognition of pathogen-associated molecular patterns. 24 Membrane-bound CD14 on monocytes, macrophages and neutrophils binds LPS and other bacterial wall products, enabling these cells to`sense' the presence of pathogens. Interaction of the LPS±LBP±CD14 complex with TLR4 and associated molecules on the membrane causes the cell to respond appropriately. 3, 4 Soluble forms of CD14, present in plasma and other biological¯uids, retain the capacity to bind LPS, and the complex formed can bind and activate both CD14-positive and CD14-negative cells, again via interactions with TLR4, providing a second pathway for cell activation. 4, 13 LBP, while not essential for association of sCD14 with LPS, accelerates assembly of the complex and thus enhances cell activation. 25 The importance of this sCD14-mediated cellactivation pathway in immune surveillance in biological¯uids, and the immunoregulatory capacity of sCD14, has only recently been recognized, ®rst in plasma, 26±27 and, even more recently, in breast milk. 16, 17 Seminal plasma is a highly specialized¯uid that is rich in immunomodulatory activities, including prostaglandins and numerous inhibitors of the complement system. 18±21,28 A delicate balance must be achieved in seminal plasma between the need to maintain powerful immune surveillance to ward off infection and the requirement to protect spermatozoa in the potentially hostile environment of the female genital tract. Because of the important immunoregulatory roles now being ascribed to sCD14, we set out to examine whether CD14 was expressed in seminal plasma and on its constituent cells.
Western blot analysis demonstrated that seminal plasma contained protein bands reactive with antibodies against CD14. spCD14, like the serum protein, comprised two major bands of approximately equal intensity; however, the band sizes had a consistently smaller M r than those in serum: 48 and 53 kDa versus 50 and 56 kDa for serum sCD14 under reducing conditions. Although we have yet formally to investigate the reason for this difference in molecular mass, it is likely to be a consequence of differences in glycosylation patterns in this heavily glycosylated glycoprotein. CD14 is GPI anchored on cells and some GPI-anchored molecules in seminal plasma, for example, CD59 and CD55, reside predominantly or exclusively on prostasomes (which are vesicular structures present in abundance in seminal plasma). 21 We examined, in two ways, the possibility that spCD59 was GPI anchored. First, ultracentrifugation to remove prostasomes demonstrated that sCD14 was not prostasome-associated, in that identical bands of similar intensity were present in prostasome-free seminal plasma (data not shown). Second, gel ®ltration of cell-free seminal plasma showed that all the CD14-reactive material was present in late fractions, compatible with GPI anchor-free protein, whereas CD59 was present predominantly in early fractions, con®rming its association with prostasomes (results not shown).
Quanti®cation by ELISA showed that the levels of sCD14 in seminal plasma were similar to the levels reported in blood plasma. Seminal plasma consists of the products of multiple components of the reproductive tract: the seminiferous tubules, the epididymis, the seminal vesicles, the prostate and the bulbourethral glands. The¯uid part is contributed chie¯y by the prostate and seminal vesicles. Transection of the vas deferens (vasectomy) removes spermatozoa and components contributed by the seminiferous tubules and epididymis. Postvasectomy, levels of sCD14 in seminal plasma were reduced to 36% of those in nonvasectomy samples, indicating that the bulk of the spCD14 was derived from testis, seminiferous tubules and/or epididymis.
Puri®cation of spCD14 by immunoaf®nity chromatography generated pure protein at a yield several fold greater than predicted from the levels measured by ELISA in seminal plasma. The probable explanation of this ®nding is that the ELISA underestimates the spCD14 concentration because of interfering components in seminal plasma. The puri®ed spCD14 was tested in assays of cell activation utilizing the CD14-negative astrocytoma line, U373, as a target, as described previously. 12, 16 spCD14 mediated the LPS-induced activation of the cells in a dose-dependent manner, as measured by three different activation parameters: secretion of IL-6; secretion of IL-8; and induction of expression of ICAM-1. The demonstration that spCD14 can mediate LPS-induced cell activation introduces the possibility that the protein may act as a sensor for LPS in vivo, activating cells in seminal plasma to respond to infection. Expression of CD14 on the membranes of spermatozoa has not previously been reported. We examined expression of CD14 on spermatozoa, obtained by swim-up to eliminate contaminating leucocytes, by¯ow cytometry and¯uorescence microscopy. One hundred per cent of spermatozoa stained for CD14 using speci®c mAb, and staining was distributed globally over the cell. The distribution of CD14 on spermatozoa was homogeneous and differed markedly from that of another GPIanchored molecule, CD59, which was distributed in clusters on the cell. Attempts to con®rm GPI anchoring of CD14 by treatment of spermatozoa with phosphatidylinositol-speci®c phospholipase C (PIPLC) were unsuccessful because of the lability of the cells under conditions used for PIPLC treatment. CD14 is predominantly expressed on cells of the myelomonocytic lineage, although it has recently become apparent that other cell types can express this molecule. Human hepatocytes, gingival ®broblasts and airway epithelia have all been show to express CD14, although its functional relevance at these sites is unclear.
29±31
The function of CD14 on human spermatozoa is uncertain. We propose that spermatozoal CD14 may have a complementary role to that of spCD14 in permitting sermatozoa to respond to LPS and other bacterial products. Spermatozoa have been shown to release reactive oxygen species (ROS) and cytokines in response to a variety of stimuli. 32, 33 Incubation of spermatozoa with LPS caused little change in the production of ROS, whereas production of ROS by seminal plasma-derived neutrophils was increased. 34 Importantly, LPS caused increased secretion of IL-6 from puri®ed human spermatozoa. 35 The mechanism of this activation was unde®ned. Taken in the context of our data it is probable that bacterial LPS can have both direct (via surface-expressed CD14) and indirect (via spCD14) activating effects on spermatozoa. LPS will also, directly or indirectly, activate neutrophils present in normal seminal plasma in small numbers (<10 5 /ml) but much increased during infection. 36 We suggest that these effects may be important in the defence against infection in the male genital tract in vivo.
In this study we have examined spCD14 expression only in normospermic and vasectomised males. It will be of interest to examine spCD14 expression in seminal plasma and on spermatozoa in males with abnormalities of spermatozoal number, structure or function, and in those with infertility of unknown aetiology. Results of such studies will give further clues to the physiological role of CD14 in the male reproductive system.
